Strategic Partnerships RIKEN actively engages in multi party collaborations with Nvidia, Fujitsu, IBM, SoftBank, and Quantinuum, signaling a strong appetite for advanced computing ecosystems. This presents a sales opportunity to provide end to end HPC infrastructure, GPU accelerated systems, system integration, and joint lab services, as well as co development programs around AI, quantum computing, and simulation software.

HPC and AI RIKEN's momentum with the Fugaku lineage and the pursuit of FugakuNEXT indicates ongoing demand for scalable high performance computing, storage, and high speed networking. Opportunities include selling next gen HPC hardware, accelerators, orchestration and workload management solutions, optimization services, and AI ML model training on large scale clusters, as well as consulting for migrating workloads to new systems.

Quantum Partnerships With IBM quantum architecture deployment and Quantinuum partnerships, RIKEN is positioned for quantum ready workflows and hybrid quantum classical compute. Potential sales avenues include quantum software development platforms, access to quantum hardware, hybrid compute consulting, algorithm development, and training programs for researchers and developers.

Open Science Platform RIKEN Open Science Portal initiative highlights a focus on data sharing, reproducibility, and interoperable research infrastructure. This opens doors for cloud hosted data platforms, data governance and cataloging services, API integration, secure data access, and collaboration tools that enable researchers to publish and reuse data across institutes, potentially through sponsored data services or cloud partnerships.

Biotech Social Impact RIKEN ReapTEC immune research work and the Virtual Fugaku project to address social issues point to opportunities in life sciences data analytics, bioinformatics HPC pipelines, digital twin simulations for healthcare and urban planning, and AI powered research workflows. Potential engagements include specialized HPC analytics for biotech, custom research software, and partnerships with pharma, hospitals, or government programs.